)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Myriad Genetics
Myriad Genetics (MYGN) investor relations material
Myriad Genetics 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary15 Jan, 2026
Strategic direction and leadership
Refined focus on the cancer care continuum, with a robust new strategy and leadership changes in the past year.
Emphasis on execution excellence, discipline in planning, and a strengthened leadership team with domain expertise.
Accelerating growth and profitability by focusing on the Cancer Care Continuum and execution excellence.
Serving large, high-growth markets in precision oncology, hereditary cancer, prenatal health, and mental health.
Over 1.5 million patient tests reported and 55,000+ healthcare providers served in 2025.
Product innovation and pipeline
Expanded portfolio in cancer care, including hereditary cancer, therapy selection, and MRD, with new launches planned through 2027.
Expanded MyRisk hereditary cancer panel launched in Q4 2025; disease-specific panels to launch in H1 2026.
First AI-enhanced Prolaris prostate cancer test to launch in H1 2026, with a second planned for 2027.
Entering the MRD market with Precise MRD, targeting breast, renal, CRC, endometrial, and ovarian cancers, with commercial launches expected in 2027.
FirstGene prenatal test offers earlier testing at 8 weeks, with commercial launch in H2 2026.
Financial performance and outlook
2025 revenue projected at $822–$824 million, with 1% overall volume growth.
2026 revenue guidance is $860–$880 million, a 6% increase, with industry-leading gross margins of 68–69%.
Adjusted EBITDA for 2026 expected at $37–$49 million, over 40% improvement from 2025.
Over $35 million planned investment in commercial expansion and R&D, with only a modest OpEx increase.
Long-term annual revenue growth targeted at high single to low double digits, driven by new product launches and partnerships.
MRD: Early adoption strategy without reimbursement
AI: How will it enhance execution excellence
What drives post-2026 revenue acceleration
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Myriad Genetics earnings date
Q4 202524 Feb, 2026
Myriad Genetics
Next Myriad Genetics earnings date
Q4 202524 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Myriad Genetics, Inc. offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage